Incyte
INCY
#1125
Rank
NZ$34.20 B
Marketcap
NZ$174.21
Share price
-1.02%
Change (1 day)
36.74%
Change (1 year)

Incyte (INCY) Fails to deliver data

Key failure to deliver metrics for Incyte:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Incyte (INCY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Incyte (INCY) - since 2013

Volume in USD (price x number of shares), data since 2013

Incyte (INCY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$23.04 M-88.38%
2024NZ$0.19 B671.36%
2023NZ$25.71 M15.22%
2022NZ$22.31 M-30.83%
2021NZ$32.26 M-42.59%
2020NZ$56.2 M156.83%
2019NZ$21.88 M-55.79%
2018NZ$49.49 M223.95%
2017NZ$15.27 M-77.94%
2016NZ$69.25 M11.56%
2015NZ$62.07 M-15.95%
2014NZ$73.85 M760.63%
2013NZ$8.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
NZ$5.75 MNZ$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.41 MNZ$9.29 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$0.21 BNZ$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$24.63 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.36 MNZ$9.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$2.53 MNZ$5.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$18.77 MNZ$0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
N/ANZ$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
N/ANZ$40.39 M๐Ÿ‡บ๐Ÿ‡ธ USA